Connection

C Pradier to Raltegravir Potassium

Back to Details
This is a "connection" page, showing publications C Pradier has written about Raltegravir Potassium.
C Pradier
Connection Strength
0.164
Raltegravir Potassium
  1. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens. HIV Med. 2018 02; 19(2):102-117.
    View in: PubMed
    Score: 0.164
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.